Sapropterin Dihydrochloride Patent Expiration
Sapropterin Dihydrochloride is used for reducing blood phenylalanine levels in patients with hyperphenylalaninemia. It was first introduced by Biomarin Pharmaceutical Inc
Sapropterin Dihydrochloride Patents
Given below is the list of patents protecting Sapropterin Dihydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kuvan |
US9216178 (Pediatric) | Dry blend formulation of tetrahydrobiopterin | May 01, 2033 | Biomarin Pharm |
| Kuvan | US9216178 | Dry blend formulation of tetrahydrobiopterin | Nov 01, 2032 | Biomarin Pharm |
| Kuvan |
US7566462 (Pediatric) | Stable tablet formulation | May 16, 2026 | Biomarin Pharm |
| Kuvan |
US8003126 (Pediatric) | Stable tablet formulation | May 16, 2026 | Biomarin Pharm |
| Kuvan | US7566462 | Stable tablet formulation | Nov 16, 2025 | Biomarin Pharm |
| Kuvan | US8003126 | Stable tablet formulation | Nov 16, 2025 | Biomarin Pharm |
| Kuvan |
US7566714 (Pediatric) | Methods and compositions for the treatment of metabolic disorders |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
US7612073 (Pediatric) | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
US7727987 (Pediatric) | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
US7947681 (Pediatric) | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
US8067416 (Pediatric) | Methods and compositions for the treatment of metabolic disorders |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
US8318745 (Pediatric) | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
US9433624 (Pediatric) | Methods and compositions for the treatment of metabolic disorders |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan |
USRE43797 (Pediatric) | Methods of administering tetrahydrobiopterin |
May 17, 2025
(Expired) | Biomarin Pharm |
| Kuvan | US7566714 | Methods and compositions for the treatment of metabolic disorders |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | US7612073 | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | US7727987 | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | US7947681 | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | US8067416 | Methods and compositions for the treatment of metabolic disorders |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | US8318745 | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | US9433624 | Methods and compositions for the treatment of metabolic disorders |
Nov 17, 2024
(Expired) | Biomarin Pharm |
| Kuvan | USRE43797 | Methods of administering tetrahydrobiopterin |
Nov 17, 2024
(Expired) | Biomarin Pharm |
Sapropterin Dihydrochloride's Family Patents
